122 results on '"Ménard, Didier"'
Search Results
2. Plasmodium falciparum ring-stage plasticity and drug resistance
3. Unveiling P. vivax invasion pathways in Duffy-negative individuals
4. PA-426 Genetic profiling of molecular markers of antimalarial resistance in areas targeted for school-based malaria chemoprevention strategies in North-Eastern, Tanzania
5. Assessing the histidine-rich protein 2/3 gene deletion in Plasmodium falciparum isolates from Burkina Faso
6. Malaria in the horn of Africa: The ongoing battle against drug resistance
7. Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
8. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso
9. Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017
10. An Update on Artemisinin Resistance
11. Modified Plasmodium falciparum Ring-Stage Survival Assay with ML10 Kinase Inhibitor
12. Ex vivo RSA and Pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017
13. Ring-stage growth arrest: Metabolic basis of artemisinin tolerance in Plasmodium falciparum
14. Malaria Elimination and Eradication
15. Santé communautaire : une alternative crédible
16. Plasmodium vivax blood stage invasion pathways: Contribution of omics technologies in deciphering molecular and cellular mechanisms
17. Passer d’une politique de santé publique à une santé publique politique : proposition du groupe miroir pour un virage paradigmatique
18. Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug target
19. Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug target
20. Compensating P. falciparum artemisinin resistance
21. Hyperendemicity of cysticercosis in Madagascar: Novel insights from school children population-based antigen prevalence study
22. La construction d’un partenariat au Cambodge
23. Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness
24. Author response: Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness
25. P. falciparum K13 mutations present varying degrees of artemisinin resistance and reduced fitness in African parasites
26. Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
27. Plasmodium falciparum K13 mutations in Africa and Asia present varying degrees of artemisinin resistance and an elevated fitness cost in African parasites
28. Decision letter: Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
29. Knowing the enemy: genetics to track antimalarial resistance
30. Effect of mass dihydroartemisinin–piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance
31. RIFINing Plasmodium–NK Cell Interaction
32. Keep the quality high: the benefits of lot testing for the quality control of malaria rapid diagnostic tests
33. Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from Central African Republic (2017–2019)
34. Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria
35. DNA Methylation Bisubstrate Inhibitors Are Fast-Acting Drugs Active against Artemisinin-Resistant Plasmodium falciparum Parasites
36. Plasmodium falciparum resistance to piperaquine driven by PfCRT
37. Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia
38. African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
39. Lack of quadruple and quintuple mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from Brazilian endemic areas
40. Absence of K13 Polymorphism in Plasmodium falciparum from Brazilian Areas Where the Parasite Is Endemic
41. Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
42. A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants
43. Multidrug-resistant Plasmodium falciparum malaria in the Greater Mekong subregion
44. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape
45. Contribution to Malaria Transmission of Symptomatic and Asymptomatic Parasite Carriers in Cambodia
46. Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism
47. Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms
48. Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
49. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
50. Drug-Resistant Polymorphisms and Copy Numbers inPlasmodium falciparum, Mozambique, 2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.